Saitoh Masakazu, Dos Santos Marcelo Rodrigues, Ebner Nicole, Emami Amir, Konishi Masaaki, Ishida Junichi, Valentova Miroslava, Sandek Anja, Doehner Wolfram, Anker Stefan D, von Haehling Stephan
Innovative Clinical Trials, Department of Cardiology and Pneumology, University Medical Center Göttingen, Robert-Koch-Straße 40, Göttingen, 37099, Germany.
Heart Institute (InCor), University of Sao Paulo Medical School, Sao Paulo, Brazil.
Wien Klin Wochenschr. 2016 Dec;128(Suppl 7):497-504. doi: 10.1007/s00508-016-1112-8. Epub 2016 Nov 16.
Inadequate nutritional status has been linked to poor outcomes in patients with heart failure (HF). Skeletal muscle wasting affects about 20% of ambulatory patients with HF. The impact of nutritional intake and appetite on skeletal muscle wasting has not been investigated so far. We sought to investigate the impact of nutritional status on muscle wasting and mortality in ambulatory patients with HF.
We studied 130 ambulatory patients with HF who were recruited as a part of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF) program. Muscle wasting was defined according to criteria of sarcopenia, i.e., appendicular skeletal muscle mass two standard deviations below the mean of a healthy reference group aged 18-40 years. Nutritional status was evaluated using the Mini-Nutritional Assessment-Short Form (MNA-SF). Functional capacity was assessed as peak oxygen consumption (peak VO) by cardiopulmonary exercise testing, 6‑minute walk testing, and the Short Physical Performance Battery (SPPB).
At baseline, 19 patients (15%) presented with muscle wasting. Patients with muscle wasting had significantly lower values of peak VO, 6‑minute walk distance, SPPB, and MNA-SF score than patients without (all p < 0.05). In multivariate analysis, MNA-SF remained an independent predictor of muscle wasting after adjustment for age and New York Heart Association class (odds ratio [OR] 0.66; confidence interval [CI] 0.50-0.88; p < 0.01). A total of 16 (12%) patients died during a mean follow-up of 21 months. In Cox regression analysis, MNA-SF (OR 0.80, CI 0.64-0.99, p = 0.04), left ventricular ejection fraction (OR 0.93, CI 0.86-0.99, p = 0.05), and peak VO (OR 0.78, CI 0.65-0.94, p = 0.008) were predictors of death.
MNA-SF is an independent predictor of muscle wasting and mortality in ambulatory patients with HF. Nutritional screening should be included as a fundamental part of the overall assessment of these patients.
营养状况不佳与心力衰竭(HF)患者的不良预后相关。骨骼肌萎缩影响约20%的非卧床HF患者。迄今为止,尚未研究营养摄入和食欲对骨骼肌萎缩的影响。我们试图研究营养状况对非卧床HF患者肌肉萎缩和死亡率的影响。
我们研究了130例非卧床HF患者,这些患者是作为调查加重心力衰竭合并症研究(SICA-HF)项目的一部分招募的。根据肌少症标准定义肌肉萎缩,即四肢骨骼肌质量比18 - 40岁健康参考组的平均值低两个标准差。使用微型营养评定简表(MNA-SF)评估营养状况。通过心肺运动试验、6分钟步行试验和简短体能状况量表(SPPB)评估功能能力,以峰值耗氧量(峰值VO)表示。
在基线时,19例(15%)患者出现肌肉萎缩。与未出现肌肉萎缩的患者相比,出现肌肉萎缩的患者的峰值VO、6分钟步行距离、SPPB和MNA-SF评分显著更低(所有p < 0.05)。在多变量分析中,调整年龄和纽约心脏协会分级后,MNA-SF仍然是肌肉萎缩的独立预测因素(比值比[OR] 0.66;置信区间[CI] 0.50 - 0.88;p < 0.01)。在平均21个月的随访期间,共有16例(12%)患者死亡。在Cox回归分析中,MNA-SF(OR 0.80,CI 0.64 - 0.99,p = 0.04)、左心室射血分数(OR 0.93,CI 0.86 - 0.99,p = 0.05)和峰值VO(OR 0.78,CI 0.65 - 0.94,p = 0.008)是死亡的预测因素。
MNA-SF是非卧床HF患者肌肉萎缩和死亡率的独立预测因素。营养筛查应作为这些患者全面评估的基本组成部分。